Analysts’ Updated EPS Estimates for July 28th (ACI, AMKR, APLD, AZN, BIG, CAPR, CDNS, COIN, CORZ, CRNX)

Analysts’ updated eps estimates for Tuesday, July 28th:

Albertsons Companies (NYSE:ACI) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a $12.00 target price on the stock, down from their previous target price of $20.00.

Amkor Technology (NASDAQ:AMKR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $90.00 target price on the stock.

Applied Digital (NASDAQ:APLD) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $83.00 price target on the stock.

AstraZeneca (LON:AZN) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a £160 target price on the stock.

AstraZeneca (LON:AZN) had its sell rating reissued by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a £115 price target on the stock.

Big Technologies (LON:BIG) had its hold rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 105 target price on the stock.

Capricor Therapeutics (NASDAQ:CAPR) had its neutral rating reaffirmed by analysts at Alliance Global Partners. Alliance Global Partners currently has a $7.00 target price on the stock.

Cadence Design Systems (NASDAQ:CDNS) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $400.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $240.00 target price on the stock.

Core Scientific (NASDAQ:CORZ) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $29.00 target price on the stock.

Core Scientific (NASDAQ:CORZ) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $38.00 price target on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its neutral rating reiterated by analysts at UBS Group AG. The firm currently has a $85.00 target price on the stock, up from their previous target price of $55.00.

CommVault Systems (NASDAQ:CVLT) had its neutral rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $133.00 price target on the stock.

Cranswick (LON:CWK) had its hold rating reiterated by analysts at Berenberg Bank. They currently have a GBX 5,770 target price on the stock.

Cranswick (LON:CWK) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 6,300 target price on the stock.

dotdigital Group (LON:DOTD) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 135 target price on the stock.

DSW Capital (LON:DSW) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Everplay Group (LON:EVPL) had its buy rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 430 price target on the stock.

Flowtech Fluidpower (LON:FLO) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 100 target price on the stock.

Gaming Realms (LON:GMR) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 56 price target on the stock.

Lendingclub (NASDAQ:HAPN) had its buy rating reissued by analysts at BTIG Research. They currently have a $25.00 target price on the stock.

Humacyte (NASDAQ:HUMA) had its buy rating reiterated by analysts at BTIG Research. They currently have a $2.00 target price on the stock.

Inchcape (LON:INCH) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,170 target price on the stock.

Kistos (LON:KIST) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 325 price target on the stock.

Coca Cola Femsa (NYSE:KOF) had its hold rating reissued by analysts at HSBC Holdings plc. HSBC Holdings plc currently has a $116.00 price target on the stock.

Kura Oncology (NASDAQ:KURA) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $36.00 target price on the stock.

Legend Biotech (NASDAQ:LEGN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $65.00 target price on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $25.00 price target on the stock.

Meta Platforms (NASDAQ:META) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $800.00 price target on the stock.

Morgan Sindall Group (LON:MGNS) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 5,800 target price on the stock.

Maplight Therapeutics (NASDAQ:MPLT) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $21.00 price target on the stock, down from their previous price target of $34.00.

Microsoft (NASDAQ:MSFT) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $550.00 price target on the stock.

NewRiver REIT (LON:NRR) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Navitas Semiconductor (NASDAQ:NVTS) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $21.00 price target on the stock.

Navitas Semiconductor (NASDAQ:NVTS) had its neutral rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $13.00 target price on the stock.

NWF Group (LON:NWF) had its hold rating reissued by analysts at Shore Capital Group Ltd. The firm currently has a GBX 145 price target on the stock.

Nextpower (NASDAQ:NXT) had its buy rating reissued by analysts at Roth Capital. Roth Capital currently has a $175.00 price target on the stock.

PCI-PAL (LON:PCIP) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 115 price target on the stock.

Portmeirion Group (LON:PMP) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 100 price target on the stock.

D-Wave Quantum (NYSE:QBTS) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $43.00 target price on the stock.

Rivian Automotive (NASDAQ:RIVN) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $19.00 target price on the stock.

Rambus (NASDAQ:RMBS) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $165.00 target price on the stock.

Restore (LON:RST) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 435 target price on the stock.

Redwood Trust (NYSE:RWT) had its buy rating reiterated by analysts at BTIG Research. They currently have a $6.00 price target on the stock.

Sirius XM (NASDAQ:SIRI) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $45.00 target price on the stock.

SSP Group (LON:SSPG) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Universal Health Services (NYSE:UHS) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $194.00 target price on the stock.

Unite Group (LON:UTG) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 623 price target on the stock.

Vericel (NASDAQ:VCEL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $70.00 target price on the stock.

Vesuvius (LON:VSVS) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 440 target price on the stock.